AbbVie and Trump Administration Reach Tariff Relief Deal, Pledge $100B Investment in R&D and Manufacturing.

lunes, 12 de enero de 2026, 11:08 pm ET1 min de lectura
ABBV--

AbbVie has reached a deal with the Trump administration to reduce drug prices and invest $100 billion in US R&D and capital investments, including manufacturing, over the next decade in exchange for tariff relief. The three-year deal aims to lower drug prices and boost investment in the US economy.

AbbVie and Trump Administration Reach Tariff Relief Deal, Pledge $100B Investment in R&D and Manufacturing.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios